The Pharmaceutical Market: Sweden

Publication Date	April 2009
Publisher	Espicom
Product Type	Report
Pages	92
ISBN Number	not applicable
Product Code	ESP00020

Buy this product or for assistance call +44 20 7060 7474

PDF £595.00$975 | €694

FAX Order above formats by FAX

Summary

Espicom's in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.

Content

EXECUTIVE SUMMARY
Introduction
Pharmaceutical Market Analysis
- Size
- Market Structure
- Apoteket AB
- Generics
- Generic Substitution
- OTC Products
- Projections
- Outlook
- Imports
- Domestic Manufacturing
- Domestic Production
- Trade Associations
- Domestic Producers
- Clean Chemicals Sweden AB (CCS)
- Orion Pharma AB
- Multinationals
- AstraZeneca
- Eli Lilly Sweden AB
- Ferring AB
- Pfizer AB
- sanofi-aventis AB
- Exports
- Research & Development
- Biotechnology Developments
Pharmaceutical Regulatory Analysis
- Pharmaceutical Regulation
- EU Drug Regulation
- Centralised Procedure
- EMEA
- Generic Drugs
- National Procedures
- Marketing Authorisations
- Registration Fees
- Market Authorisation Fees
- Annual Registration Fees
- Labelling & Packaging
- Post-Marketing Surveillance
- Clinical Trials
- Pharmaceutical Product Approvals
- Intellectual Property
- Supplementary Protection Certificates
- Data exclusivity
- Pricing and Reimbursement
- Financing of medicines
- Criteria for reimbursement
- Cost effectiveness
- Price of drugs
- Expert board makes decisions
- Appealing Decisions
Pharmaceutical Distribution
- Pharmacies
- Distributors
- Tamro Sweden
- Kronans Droghandel AB (KD AB)
- Wholesale Distribution Authorisation
- Parallel Imports
Healthcare Analysis
- Demographics
- Population
- Birth Rate
- Death Rate
- Infant Mortality
- Life Expectancy at Birth
- Public Health
- Causes of Death
- Incidence of Communicable Diseases/ Morbidity
- HIV/ AIDS
- Cancer Incidence
- Healthcare System
- Health Expenditure
- Council Financing
- Healthcare Infrastructure
- Inpatient Analysis
- Ambulatory Care
- Healthcare Personnel
DIRECTORY
- Healthcare Organisations
- Trade Associations and Manufacturers
- Distributors
- Methodology and Sources
List of Tables
- Key Data Projections, 2009-2014
- Summary of the Swedish Pharmaceutical Market, 2009
- Pharmaceutical Market by Type, 2007
- Pharmaceutical Expenditure at Pharmacy Purchase Prices, 1980-2007
- Number of Prescriptions, 2000-07 (millions)
- Drug costs by category, 2003-07 (SEK millions)
- Leading Pharmaceutical Manufacturers by Sales, 2007
- Leading Products by Sales, 2007
- Leading Pharmaceutical Groups by Sales, 2007
- Sales by Therapeutic Group at Pharmacy Purchase Prices, 2000-07 (SEK millions)
- Apoteket AB Pharmaceutical Sales by Sector at Retail Prices, 1991-2007 (SEK millions)
- Price decline for off-patent drugs
- OTC Sales by Leading Product Groups, 2007
- OTC sales by category, 2006-07 (SEK millions)
- Leading OTC Drugs, 2006-07 (SEK millions)
- Projected Pharmaceutical Market, 2009-2014
- Espicom Analysis of the Swedish Pharmaceutical Market, 2009
- SWOT Analysis of the Swedish Pharmaceutical Market
- Imports of Pharmaceuticals by Category, 2004-08 (US$000s)
- Pharmaceutical Import Trends
- Leading Suppliers of Raw Materials, 2008 (US$000s)
- Leading Suppliers of Medicaments, 2008 (US$000s)
- Swedish Pharmaceutical Production, 2003-07 (euros 000s)
- Domestic Production, 2001-2004 (SEK 000s)
- Exports of Pharmaceuticals, 2004-08 (US$000s)
- Pharmaceutical Export Trends
- Leading Destinations, 2008 (US$000s)
- Number of Projects by Therapeutic Category, 2007
- Marketing Authorisation Fees (SEK)
- Annual Registration Fees (SEK)
- Approved Pharmaceutical Products, 1985-2007
- Approved New Chemical Entities and Average Processing Period, 1985-2006
- Pharmacies, 1996-2007
- Parallel Imported Pharmaceutical Market, 1997-2007
- Summary of Demographic Data, 2008
- Projected Population, 2009-2014
- Patient Charges, as of January 2009 (SEK)
- Healthcare Expenditure, 2009
- Health Expenditure by Sector, 2000-2005, Current Prices (SEK million)
- County Council Costs Per Activity or Service, 2005-07 (SEK millions)
- Projected Health Expenditure, 2009-2014
- Public Hospital Trends, 1999-2007
- Public Hospital Beds by Type, 1997-2006
- ALOS by Care Type, 2006 (Days)
- Inpatient Admissions by Disease, 2006-07
- Operations by Category, 2003-07
- Outpatient Visits to a Physician, 2004-06 (000s)
- Outpatient Visits to Doctors by County, 2006 (000s)
- Medical Personnel, 2006-07
- Projected Total Number of Physicians, 2009-2014
- Doctors and Dentists by Specialty, 2006-07
List of Figures
- Sales by Therapeutic Group, 2007
- Radar Graph of the Swedish Healthcare System
- R&D Clinical Costs, 1999-2007 (SEK billions)
- Number of projects in late pre-clinical or clinical trials phase, 2007